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Fibropapillomatosis (FP), a transmissible neoplastic disease of marine turtles characterized by a likely herpesviral
primary etiology, has emerged as an important disease in green sea turtles (Chelonia mydas) over the past three
decades. The objectives of this study were to determine the suitability of three different chelonid
fibropapilloma-associated herpesvirus (CFPHV) gene targets in polymerase chain reaction (PCR) assays of affected
tissues; to explore the presence of CFPHV in non-affected skin from turtles with and without tumors; and to better
understand tissue localization of the CFPHV genome in a tumor-free turtle by evaluating CFPHV presence in
microanatomic tissue sites. Two aggregations of green sea turtles (Chelonia mydas) in Puerto Rico were evaluated,
with six sampling intervals over the three-year period 2004–2007. Primary and nested PCR for three different
herpesviral gene targets- DNA polymerase, capsid maturation protease, and membrane glycoprotein B- were
performed on 201 skin biopsies taken from 126 turtles with and without external tumors. Laser capture
microdissection and nested PCR were used to identify tissue localizations of CFPHV in skin from a normal turtle. Of
the turtles sampled in Manglar Bay, 30.5% had tumors; at the relatively more pristine Culebrita, 5.3% of turtles
sampled had tumors. All three PCR primer combinations successfully amplified CFPHV from tumors, and from
normal skin of both tumored and tumor-free turtles. Via nested PCR, the polymerase gene target proved superior to
the other two gene targets in the positive detection of CFPHV DNA. CFPHV infection may be common relative to
disease incidence, supporting the idea that extrinsic and/or host factors could play a transforming role in tumor
expression. Laser capture microdissection revealed CFPHV in skin from a tumor-free turtle, harbored in both
epidermal and dermal tissues. Identification of CFPHV harbored in a non-epidermal site (dermis) of a tumor-free
turtle indicates that virus is latent in a non-tumored host.
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Fibropapillomatosis (FP) is a transmissible neoplastic
disease of marine turtles that is characterized by a vari-
able number of cutaneous and conjunctival growths,
with occasional appearance in visceral organs. The
tumors often cause affected animals to become debili-
tated by hampering feeding and movement, obscuring
vision, or in the case of visceral tumors, leading to organ
failure (Balazs 1986; Herbst 1994; Jacobson et al. 1989;
Quackenbush et al. 1998; Smith & Coates 1938). Over
the past three decades, FP has emerged as an important
disease in green sea turtles (Chelonia mydas), and is po-
tentially threatening to their survival. Recent studies
show that FP disease prevalence is now declining in Ha-
waiian green turtle populations; however FP prevalence
in green turtles in Florida seems to be more stable (Cha-
loupka et al. 2009; Foley et al. 2005). Better understand-
ing of the causation, pathogenesis, and diagnosis of
marine turtle FP could help greatly in control efforts
against this devastating disease.
The typical histologic description of FP includes papil-
lary epidermal hyperplasia supported by broad fibrovas-
cular stalks, with a varying ratio of epidermal to dermal
proliferation (Herbst 1994). Papillomas are characterized
by proliferating epidermis with little or no underlying
dermal involvement; lesions composed predominantly of
proliferating dermal components with a relatively nor-
mal overlying epidermis are characterized as fibromas.
Fibropapillomas are thus classified as masses in which
hyperplasia is observed in both epidermis and dermis
(Herbst 1994). Visceral tumors are typically identified as
fibromas, myxofibromas, or fibrosarcomas (Norton et al.
1990; Work et al. 2004). Visceral tumors tend to develop
late in the course of disease, and are generally perceived
as a more chronic lesion (Harshbarger 1991; Herbst
1994; Herbst et al. 1999; Jacobson et al. 1989; Lucke
1938).
The etiologic agent most often associated with FP is
an alphaherpesvirus, designated chelonid fibropapilloma-
associated herpesvirus (CFPHV). This virus has been
partially sequenced but to date has resisted isolation
attempts (Greenblatt et al. 2005; Herbst et al. 2004). The
consistent association of this virus with FP tumors, either
via polymerase chain reaction (PCR) or demonstrated
through in situ hybridization, as well as effective disease
transmissibility using cell-free tumor extracts, have
resulted in a commonly perceived causal associative link
(Herbst et al. 1995; Herbst et al. 2004; Kang et al. 2008;
Lackovich et al. 1999; Lu et al. 2000; Quackenbush et al.
2001). However, the virus has been shown to be present,
either serologically or through molecular techniques, in
some normal animals. This raises the possibility that
there are additional factors – ecologic, immunologic, or
microbial – involved in disease development (Herbstet al. 2008; Lackovich et al. 1999; Lu et al. 2000; Quack-
enbush et al. 2001).
Identification of CFPHV deoxyribonucleic acid (DNA)
in sea turtle tissues has been accomplished by various
techniques, including PCR and in situ hybridization
(Herbst et al. 1999; Kang et al. 2008; Lackovich et al.
1999; Lu et al. 2000; Quackenbush et al. 1998; Quacken-
bush et al. 2001). CFPHV DNA has been isolated from
the following tissues: cutaneous tumors (i.e., fibropapil-
lomas), tumors on the serosal surfaces of lungs, esopha-
geal mucosa, and trachea (i.e. fibromas), scar tissue
where an FP tumor was previously removed, and non-
tumored tissues- skin, lungs, kidney, heart, spleen, liver,
brain, periorbital tissue, conjunctiva, ovary, testis,
tongue, gall bladder, intestine, urinary bladder, thyroid
(Herbst et al. 1999; Jacobson et al. 1989; Kang et al.
2008; Lackovich et al. 1999; Lu et al. 2000; Quackenbush
et al. 1998; Quackenbush et al. 2001).
The sloughing of virally infected epidermal cells from
a diseased turtle into the surrounding environment is
considered a source of viral shedding. Thus FP tumors
are suggested to undergo viral shedding, as evidenced by
the presence of CFPHV-associated intranuclear viral
inclusions within cells of the epidermal strata germinati-
vum and spinosum of some cutaneous tumors (Jacobson
et al. 1989; Jacobson et al. 1991; Lackovich et al. 1999).
In one study, the high prevalence of CFPHV glycopro-
tein H antibodies in a green turtle population with 0%
tumor prevalence suggests that robust antibody
responses to natural infection may develop independ-
ently of the appearance of cutaneous tumors (Herbst
et al. 2008). Because CFPHV’s primary target seems to
be skin, early or latent infection may be represented by
the presence of CFPHV DNA in non-tumored skin from
turtles with and without tumors (Quackenbush et al.
2001). There is one report of CFPHV polymerase DNA
identified in differentiated epidermal and dermal tissues
of tumors sampled from green turtles (Work et al.
2009). To date, however, there are no previous reports
using the microanatomic location of CFPHV DNA to in-
vestigate potential viral shedding from the skin of “nor-
mal” turtles (i.e., turtles that do not have tumors). In the
present study, application of an innovative technique,
laser capture microdissection, permits a precise way to
begin assessing the role that cell type plays in disease
processes.
The study described here had three objectives. The
first was to determine the suitability of various CFPHV
gene targets in PCR assays for detection of CFPHV in
affected tissues. The second objective was to explore the
presence of CFPHV DNA in non-affected skin from
both turtles with tumors and tumor-free turtles. The
third objective was to use an innovative technology, laser
capture microdissection, to evaluate CFPHV presence in
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from a tumor-free turtle, in an effort to better identify
the tissue location of the CFPHV genome.
Results
Number of turtles sampled by location, including num-
bers of turtles with and without tumors, is presented in
Table 1. Within six sampling sessions over a three year
period, 126 turtles were captured and a total of 201 skin
biopsy samples were taken.
Three different primer sets were designed for three
CFPHV genes– DNA polymerase catalytic subunit
(UL30, pol), capsid maturation protease (UL26), and
membrane glycoprotein B (UL27, gB), and these nested
CFPHV PCR targets were confirmed according to gene
fragment size. The gene targets were further verified by
the results of the Clustalb multiple sequence alignments,
which were conducted on the three nested PCR
products- one sample of each type of nested amplicon.
Alignment of the sequences revealed that the CFPHV
DNA pol PCR product showed 100% (206/206bp) nu-
cleotide sequence similarity; the capsid maturation
protease PCR product showed 99.4% (322/324bp) nu-
cleotide sequence similarity; and the membrane glyco-
protein B PCR product showed 100% (300/300bp)
nucleotide sequence similarity when compared to pre-
dicted homologous nucleotide sequences for Hawaiian
green turtle herpesvirus, GenBanka AF035003 (data not
shown).
Results of the primary and nested PCRs for the three
target sequences, i.e., DNA pol, capsid maturation prote-
ase, and membrane glycoprotein B, are shown in Table 2.
Of the 38 tumor tissues, 89.5% were positive for the
polymerase gene target by either primary or nested PCR.
Primary PCR for the polymerase gene target was positive
for six tumors, whereas nested PCR was positive for
polymerase for all but five tumors (86.8%).
Primary PCR for the capsid maturation protease gene
target was positive in three tumors; nested PCR was
positive for capsid maturation protease in 23 tumors.
Primary PCR for the virion membrane glycoprotein B
gene target was positive in three tumors; nested PCR
was positive for glycoprotein B in 29 tumors.
In all but one case, when turtles with tumors were








Manglar 69 18 51
Culebrita 57 3 54
TOTALS 126 21 105collected. None of these 21 skin biopsies were positive
by primary PCR, but 47.6% were positive for CFPHV
using the nested PCR technique.
Additionally, skin samples were taken from 105 turtles
that had no evidence of tumors, and assayed for pres-
ence of CFPHV. Of 142 skin biopsies taken from the
105 normal animals sampled, 32.4% were positive for
nucleic acid of the virus by PCR. Of these, only 4.3%
were positive using the primary PCR technique, and one
of these was positive for both capsid maturation protease
and membrane glycoprotein B. Of the 46 skin samples
which tested positive by nested PCR, 39.1% were positive
for both polymerase and capsid maturation protease.
Three other normal skin samples were only positive via
nested PCR for membrane glycoprotein B.
Using laser capture microdissection, DNA extraction,
and the DNA pol target nested PCR protocol, CFPHV
DNA was detected in both epidermal and dermal tissues
from the skin of a non-tumored turtle. Distinct bands
were visualized in the approximately 364bp region of the
gel for both epidermal and dermal samples, consistent
with the positive control for the CFPHV DNA polymer-
ase gene target. The nested PCR product sequences
representing the differentiated dermis and epidermis
samples were subjected to Clustalb multiple sequence
alignment to verify the gene targets. Comparison of the
dermis CFPHV DNA polymerase PCR product showed
96% (288/300bp) nucleotide sequence similarity; and
comparison of the epidermis CFPHV DNA polymerase
PCR product showed 98% (331/338bp) nucleotide se-
quence similarity when compared to predicted homolo-
gous nucleotide sequences for the Hawaiian green turtle
herpesvirus DNA polymerase catalytic subunit gene pol
(GenBanka AF035003). The dermis CFPHV PCR product
was noted to be relatively impure, which could explain
the low sequence similarity obtained for this product as
compared to the other sequences reported here.
Discussion
Of the turtles sampled in Manglar Bay during these six
sampling sessions, 30.5% had tumors. At the relatively
more pristine Culebrita, 5.3% of turtles sampled had
tumors. A Fisher’s exact test revealed a significant asso-
ciation between proportion of turtles with FP and loca-
tion (Manglar Bay vs. Culebrita, p = 0.0005, α = 0.05).
Historical records provided by the Puerto Rico Depart-
ment of Natural Resources indicate that in past surveys
tumors were common in turtles found in Manglar Bay
but rare in turtles within the Culebrita aggregation. Spe-
cifically, turtles with FP were reported at Manglar Bay
with high to medium prevalence, i.e. 57% in 2001–2005
and 30% in 2006–2007 (Diez et al. 2010). In more recent
years, however, FP prevalence has been reported to be as
low as 0% at Manglar Bay (Patricio et al. 2011). Sampling
Table 2 Number of positive amplifications of target gene partial sequences * P = primary PCR; N = nested PCR
Description of Samples DNA target type*
Polymerase Capsid protease Glycoprotein B
Location Type of tissue Number P N P N P N
Manglar Tumor 29 4 24 3 21 1 20
Skin from turtle with tumor 18 0 8 0 9 0 5
Skin from normal turtle 71 0 21 1 19 0 17
Culebrita Tumor 9 2 9 0 2 2 9
Skin from turtle with tumor 3 0 1 0 1 0 1
Skin from normal turtle 71 0 13 1 7 1 9
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until 2009, when a 40% FP disease prevalence was
observed in green turtles captured there (Patricio et al.
2011; Velez-Zuazo et al. 2010).
In this study, the tumors were collected immediately
into formalin and then after 12–24 hours, changed to
RNase-free PBS. This was logistically necessary, due to
the tropical working environment- the high ambient
temperatures made it impossible to keep ice frozen for
the duration of an entire sampling day. Although this
technique worked even with brief formalin fixation, in
future studies if freezing the tissues is not feasible a
more appropriate technique will be employed to con-
serve the DNA, such as use of 98% ethanol or a ribo-
nucleic acid (RNA) stabilization reagent.c
One aim of this study was to determine the suitability
of various CFPHV gene targets in PCR assays for detec-
tion of CFPHV in affected tissues. To accomplish this,
we tested three different gene targets for the CFPHV
genome, and applied primary and nested PCR assays to
detect the DNA in both tumored and non-tumored tis-
sues. The PCR technique was successful at amplifying
the virus from tumors, with polymerase nested PCR per-
forming the most consistently. All but one of the 34
CFPHV-positive tumors yielded a positive result using
the nested PCR technique for the polymerase gene target
(97.2%). Our results are comparable to other studies
which have described the use of nested PCR technique
for polymerase gene target to detect CFPHV DNA in
tumor tissues. The CFPHV DNA was detected in 100%
and 95.7% of tumors examined from green turtles in Ha-
waii and Florida, respectively (Lackovich et al. 1999; Lu
et al. 2000). The study reported here is an important
addition to previous work because it compares three dif-
ferent gene targets for CFPHV DNA detection. As
expected, the polymerase gene target proved to be su-
perior to the capsid maturation protease and membrane
glycoprotein B gene targets in the positive detection of
CFPHV DNA. It is vital, however, not to overlook the
utility of the alternative gene targets. The one tumor
which was negative by nested PCR for polymerase waspositive for CFPHV DNA by nested PCR for both capsid
maturation protease and membrane glycoprotein B. So,
the overall sensitivity of viral detection may be improved
in future studies by the use of these additional targets.
Another aim of this study was to explore the presence
of CFPHV DNA in non-tumored skin taken from turtles
with and without tumors. In addressing this aim, we
found that several normal skin samples taken from
tumored turtles were CFPHV positive by PCR. Of 21 bi-
opsies taken from normal shoulder skin in animals that
had tumors at other sites, 47.6% were positive by nested
PCR for the polymerase gene and occasionally the other
two DNA targets. These results agree with those of previ-
ous reports documenting CFPHV DNA in normal skin
from turtles with tumors. In two studies conducted in
Hawaiian green turtles with tumors, 57.1% and 93.3% of
skin samples were positive by nested PCR for the poly-
merase gene, respectively (Lu et al. 2000; Quackenbush
et al. 1998). In normal skin sampled from tumored green
turtles in Australia, 45.5% of samples were positive for
the polymerase gene by quantitative PCR (Quackenbush
et al. 2001).
The CFPHV DNA was also detected in skin from
“normal” turtles, i.e., those without any apparent tumors.
There were 105 normal turtles captured and biopsied,
and 32.4% of 142 biopsy samples were positive for
CFPHV. None of these were positive by primary PCR
for the polymerase gene, whereas 34 were positive by
the nested PCR technique. These results are similar to
those reported from another part of the world. Of skin
samples from 14 normal green turtles in Australia,
21.4% were positive for the CFPHV polymerase gene by
quantitative PCR (Quackenbush et al. 2001). However,
the findings in our study are also contradictory to some
other published reports. In a study on non-tumored,
stranded green turtles in Florida, all skin samples were
negative by nested PCR for the CFPHV polymerase gene
(Lackovich et al. 1999). In two studies conducted in Ha-
waiian green turtles, all skin samples from normal green
turtles were negative by nested PCR (Lu et al. 2000;
Quackenbush et al. 1998). The differences in these
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variations can be expected based on the widely different
geographic regions, population genetics, and overall en-
vironmental considerations. But also, some of the differ-
ences in the reported works may be a function of sample
size. The work presented here represents a significant
contribution to the existing research because the sample
size is considerably larger than any previously reported,
and may be a more accurate representation of the true
nature of the situation.
Separation of dermis and epidermis can be accom-
plished by gross dissection alone; however, dissection of
tissues inherently could lead to sample contamination by
unsolicited cell types. Laser capture microdissection
allows for precise localization of a specific segment of
nucleic acid within a histologic section. As such, this
technique was applied to address the third aim of our
study: to better identify the precise tissue location of the
CFPHV genome in skin sampled from a non-tumored
turtle. We employed laser capture microdissection to de-
termine whether CFPHV DNA in a non-tumored sec-
tion of skin might be harbored in epidermis or dermis,
or both. We specifically chose to use skin from a “nor-
mal” turtle, and we used a biopsy that had previously
been shown to contain CFPHV nucleic acid via PCR.
Separating samples from epidermis and dermis yielded
surprising results- the viral nucleic acid was present in
both portions. A previous study documents CFPHV
DNA in both dermis and epidermis of FP tumors, with
higher levels in the dermis (Work et al. 2009). Because
viral particles have routinely been observed in epidermal
cells of tumored skin, it is generally assumed that
tumored skin undergoes viral shedding, at least periodic-
ally, and that transmission may occur in this manner.
But our findings are notable in that we also found viral
nucleic acid in differentiated tissues of normal turtle
skin, suggesting there may be viral shedding from non-
tumored turtles as well. Additionally, the identification
of viral nucleic acid in dermis as well as epidermis raises
the possibility that the infection is much more than an
epidermal infection, but that there may be systemic cells
that also harbor the virus.
Conclusions
The results of this study constitute a meaningful contri-
bution to related evidence that CFPHV infection may be
common relative to disease incidence, and support the
idea that aspects of the environment and host may play
a transforming role in FP disease expression. This idea is
further supported by phylogenetic analyses of CFPHV
which show evidence of low viral mutability, suggesting
coevolution of the virus with marine turtle hosts over
millennia and a potential for external factors to affect
disease expression (Herbst et al. 2004; Patricio et al.2012). It is known that turtles develop FP after they re-
cruit to nearshore habitat locations as juveniles (Ene
et al. 2005; Herbst et al. 2008). Previous studies show
that land use near areas where turtles feed may influence
disease rates, with elevated FP incidence grouped in
watersheds with high nitrogen-footprints (Dailer et al.
2010; dos Santos et al. 2010; Van Houtan et al. 2010).
Sites with high FP prevalence, such as the Manglar Bay
sampling site in this study, may serve to amplify the dis-
ease transmission cycle, since tumors are a known
source of viral transmission (Herbst et al. 1995; Herbst
et al. 1996; Herbst et al. 2008). Future studies involving
laser capture microdissection should include evaluation
of a larger sample size to validate the accuracy of our
conclusions. Determining exactly which circulating cells
may be infected could have great value in further under-




In the Culebra archipelago of eastern Puerto Rico, two
aggregations of green sea turtles were sampled for
tumors over a period of three years. One aggregation
was sampled in Manglar Bay, a basin on the island of
Culebra which has relatively high levels of human activ-
ities and waste water runoff (18-18'13“ N, 065-15019” W).
The other aggregation was sampled at the more pristine
cay preserve of Culebrita (18-18053“ N, 065-13044” W).
Based on telemetry data tracking the movements of tur-
tles found in Manglar Bay, these two aggregations were
thought to commingle at night at a reef between the two
sites (Diez et al. 2010). This is an assumption, however,
since transmitters were not deployed on turtles found at
Culebrita. According to mitochondrial DNA analysis,
Manglar Bay and Culebrita green turtle aggregations re-
cruit from multiple rookeries belonging to all five Atlan-
tic and Caribbean Regional Management Units (Velez-
Zuazo et al. 2010; Wallace et al. 2010).
A total of 126 green turtles were captured by netting
and subsequently released, during six different time
intervals over the three-year period 2004–2007. All were
classified as juveniles, defined by a curved carapace
length < 65 cm (Patricio et al. 2011). Because to date
there is no available report on the somatic growth and
maturity stages of these aggregations, this age-size classi-
fication is arbitrary; however it is based on similar,
previously used classifications (Bresette et al. 2010;
Chaloupka & Limpus 2001).
Biopsy procedure
Following disinfection (Betadine) of the sampling tissue,
tumors and/or normal skin from affected animals were
either surgically removed or biopsied using a 6mm
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tumored skin on the shoulder area was also taken from
all animals, whether or not they were affected by FP.
Tissues were placed in 10% buffered formalin for 12–24
hours, then cut in half and placed in diethyl pyrocarbo-
nate (DEPC) treated phosphate-buffered saline (PBS, pH
7.6) and kept at 4°C. After transportation to the labora-
tory (1–2 weeks), they were kept at -80°C until assayed.
All procedures were performed under the regulatory au-
thorities of federal and state permit (US NMFS: Permit
NO. 1253 and PRDRNA 12-EPE-04) and Animal Care
and Use Protocols at the University of Georgia.
PCR and sequencing protocol
Up to 25mg of tissue was minced into small pieces and
placed into a 1.5ml microcentrifuge tube with 200μl of
tissue lysis buffer containing 600mAU of Proteinase K.d
Tissues were incubated at 55°C until completely dis-
solved. Total DNA was extracted using the DNeasy tis-
sue kit.d Final concentration was determined by
spectrophotometric analysis, using the ratios of absorp-
tion at 260nm versus 280nm to ensure DNA purity. A
final concentration of 0.1-1 μg/μl was used for the PCR
reactions. The oligonucleotide primers were designed
according to the Hawaii green turtle herpesviral (fibro-
papilloma) genes, GenBanka AF035003, representing a
highly conserved region of the herpesviral DNA (Green-
blatt et al. 2005; Quackenbush et al. 1998; Quackenbush
et al. 2001). Three different pairs of primers were
designed for three different genes of the herpesvirus –
DNA polymerase catalytic subunit (UL30, pol), capsid
maturation protease (UL26), and membrane glycopro-
tein B (UL27, gB). All primers were manufactured by
Integrated DNA Technologies, Inc.e
The primary PCR primers and nested PCR primers
were designed as follows: the forward and reverse pri-
mers for the primary PCR target to DNA polymerase
catalytic subunit pol (50 —AGC ATC ATC CAG GCC
CACA AT CTG— 30, 50 —CGG CCA GTT CCG GCG
CGT CGA CCA— 30, respectively) result in an amplifi-
cation product of approximately 445bp. These primers
were used exactly as described by previous investigators
(Lu et al. 2000). The forward and reverse primers for the
nested PCR target to DNA polymerase catalytic subunit
(50 —CGG CGA GCC GAA ACG CTC AAG G— 30, 50
—TCC GTT CCC CAG CGG GTG TGA A— 30) result
in an amplification product of approximately 364bp.
The primary and nested PCR primers of capsid matur-
ation protease were designed according to the 3357 to
5006 region of the Hawaiian green turtle herpesviral
gene (GenBanka AF035003), using Primer3 softwaref.
The forward and reverse primers for the primary PCR
target to capsid maturation protease (50 —AGA GCG
AGG GTT TAG GCT GGA C— 30, 50 —CAA TGCCGC CCT TCC TCG TCG G— 30, respectively) result
in an amplification product of approximately 495bp, and
the forward and reverse primers for the nested PCR tar-
get to capsid maturation protease (50 —GAT CAC AAG
GAC CGA TGC ACG G— 30, 50 —AGC GGT TTC
ATC GTA TAT CGC G— 30, respectively) result in an
amplification product of approximately 324bp.
The primary and nested PCR primers of membrane
glycoprotein B were designed according to the 5155 to
7713 region of the Hawaiian green turtle herpesviral
gene (GenBanka AF035003), using Primer3 softwaref.
The forward and reverse primers for the primary PCR
target to virion membrane glycoprotein B (50 —GTG
CGC ACT TCC GTA ATC TCG TCC— 30, 50 —CAG
AGA CGC CAC CTT TAC TCA GGT— 30, respect-
ively) result in an amplification product of approximately
534bp, and the forward and reverse primers for the
nested PCR target to virion membrane glycoprotein B
(50 —AGT AGG GAA GCA GCT CGT TGT G— 30, 50
—CGA CGT AAC GGT ATG GGA GCT G— 30, re-
spectively) result in an amplification product of approxi-
mately 300bp.
To ensure that our findings were not the result of con-
tamination, PCRs were run with two negative controls-
both a chicken liver genome template and no genome
template. The PCR products were electrophoresed to de-
termine size, along with equivalent plasmid inserts for
comparison. Prior to this study, the three gene targets
were each cloned into plasmids, and the sequences were
verified via multiple sequence alignment (Kang et al.
2008). These equivalent plasmid inserts were electro-
phoresed along with all test samples for size comparison,
as positive controls. The PCR products with the same
size and corresponding plasmid type were considered a
positive product. The PCR products were resolved on
1% agarose gels. For three PCR products (one sample of
each type of nested amplicon), bands of the appropriate
size were excised and purified using the QIAquick Gel
Extraction Kit.d Capillary (Sanger) DNA sequencing was
performed using the BigDye Terminator Kitg, and ana-
lyzed on a 3730 XL, 96-well capillary electrophoresis
DNA sequencing systemg at the Georgia Genomics Fa-
cility at the University of Georgia. Viral sequences were
compared to the Hawaiian green turtle herpesvirus,
GenBanka AF035003, using Clustalb multiple sequence
alignment to verify the gene targets according to DNA
identity.
Laser capture microdissection protocol
The biopsy sample evaluated was composed of non-
tumored skin removed from the shoulder of a turtle
without tumors. The tissue was placed in 10% buffered
formalin for 1–2 weeks, then placed in a tissue cassette
and embedded in paraffin. Paraffin-embedded tissue was
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on a polyethylene naphthalate, 1.35μm membrane-slide.
The tissue sections were stained using routine
hematoxylin and eosin staining techniques. Epidermal
and dermal tissues were microscopically visualized and
differentiated, and four samples from each of the two
tissue types were traced and microdissected. Microdis-
sected samples were then cleanly removed using two
separate isolation caps, one for each tissue type, which
rested on a membrane and thus had no direct contact
with the specimen.h The membranes, contained within
1.5ml microcentrifuge tubes, were inundated with 180μl
of tissue lysis buffer and 12mAU of Proteinase K.d Tis-
sues were successively incubated at 56°C and 90°C until
completely dissolved. Total DNA was extracted using a
DNA FFPE Tissue Kit,d and primary and nested PCR for
the polymerase gene target were performed, as previ-
ously described. The negative control of no genome
template was used in these PCR assays; as a positive
control, we used the DNA polymerase catalytic subunit
pol equivalent plasmid insert as described above. The
dermis and epidermis PCR products were resolved on a
1% agarose gel, and bands of the appropriate size were
excised, purified using the QIAquick Gel Extraction Kitd,
and sequencedg by the Georgia Genomics Facility at the
University of Georgia as previously described. These
viral sequences were compared to that of the Hawaiian
green turtle herpesvirus, GenBanka AF035003, using
Clustalb multiple sequence alignment to verify the gene
target according to DNA identity.Endnotes
aGenBank, National Center for Biotechnology Infor-
mation, Bethesda, MD.
bClustal W/X software, version 2.0.12, Conway Insti-
tute UCD, Dublin, Ireland.
cRNAlater, Qiagen, Valencia, CA USA.
dQiagen, Valencia, CA USA.
eIntegrated DNA Technologies (IDT), Coralville, IA
USA.
fPrimer3 software, version 0.4.0, Humana Press,
Totowa, NJ USA.
gApplied Biosystems, Life Technologies Corporation,
Carlsbad, CA USA.
hMolecular Machines and Industries, Haslett, MI USA.Abbreviations
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